Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Baum

Showing results (281-290 of 470) with videos related to

Pageof 47
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
<sup>177</sup>Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning KidneyJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Nuclear Medicine Communications|December 16, 1998
Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumours: comparison with the expression of the Ki-67 antigenS Adams, R P Baum, A Hertel, et al.
Life Sciences and Space Research|January 1, 1972
Test of a life support system with Hirudo medicinalis in a sounding rocketR G Lotz, P Baum, G H Bowman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2007
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?P Antunes, M Ginj, H Zhang, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 15, 2011
Current treatment options for neuroendocrine tumorsD Hörsch, P Grabowski, C P Schneider, et al.
Theranostics|January 2, 2024
Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs)Richard P Baum, Peipei Wang, Vivianne Jakobsson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2010
Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody moleculesRichard P Baum, Vikas Prasad, Dirk Müller, et al.
Scientific Reports|March 15, 2019
Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their originRebekka Mai, Daniel Kaemmerer, Tina Träger, et al.
The British Journal of Dermatology|August 1, 1995
In situ detection of retinoid-X receptor expression in normal and psoriatic human skinJ Reichrath, T Münssinger, A Kerber, et al.
Nuclear Medicine Communications|October 1, 1987
CA-19-9 and CEA in the differential diagnosis of isolated liver metastases compared to clinical laboratory testsM Lorenz, C Hottenrott, R P Baum, et al.
Pageof 47

Showing results (281-290 of 470) with videos related to

Sort By:
Pageof 47
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
<sup>177</sup>Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning KidneyJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Nuclear Medicine Communications|December 16, 1998
Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumours: comparison with the expression of the Ki-67 antigenS Adams, R P Baum, A Hertel, et al.
Life Sciences and Space Research|January 1, 1972
Test of a life support system with Hirudo medicinalis in a sounding rocketR G Lotz, P Baum, G H Bowman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 17, 2007
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?P Antunes, M Ginj, H Zhang, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 15, 2011
Current treatment options for neuroendocrine tumorsD Hörsch, P Grabowski, C P Schneider, et al.
Theranostics|January 2, 2024
Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs)Richard P Baum, Peipei Wang, Vivianne Jakobsson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2010
Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody moleculesRichard P Baum, Vikas Prasad, Dirk Müller, et al.
Scientific Reports|March 15, 2019
Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their originRebekka Mai, Daniel Kaemmerer, Tina Träger, et al.
The British Journal of Dermatology|August 1, 1995
In situ detection of retinoid-X receptor expression in normal and psoriatic human skinJ Reichrath, T Münssinger, A Kerber, et al.
Nuclear Medicine Communications|October 1, 1987
CA-19-9 and CEA in the differential diagnosis of isolated liver metastases compared to clinical laboratory testsM Lorenz, C Hottenrott, R P Baum, et al.
Pageof 47